Thylacine Biotherapeutics Wins Medical Threat Reduction Challenge With Antiviral Platform
Thylacine Biotherapeutics has won first place in the Medical Threat Reduction Challenge organized by Advanced Technology International and the Medical CBRN Defense Consortium. Beating over 300 submissions and 14 finalists, the company’s broad-spectrum antiviral platform impressed the judges with its potential to combat a wide range of viral threats, Thylacine said. Thylacine’s platform, developed at […]